Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546363 · ClinicalTrials.gov registry record
Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 95
- Enrollment target
NCT01546363: Completed study, sponsored by Stanford University.
NCT01546363 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01546363 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.
Interventions
- OTHER Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2012-02-24 |
| Est. Completion | 2020-06-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546363
The ClinicalTrials.gov registry entry for NCT01546363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT01546363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01546363 about?
NCT01546363 is a clinical study titled "Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer". The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse...
What is the current status of trial NCT01546363?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2012-02-24. Estimated completion is 2020-06-29.
What interventions are being tested in trial NCT01546363?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT01546363?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.